DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.
D000284:Administration, Oral; D000311:Adrenal Glands / Q000502:physiology; D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002421:Caudate Nucleus / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D005998:Glycine; D006719:Homovanillic Acid / Q000378:metabolism; D007668:Kidney / Q000502:physiology; D007930:Leucine; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D010053:Ovary / Q000502:physiology; D010280:Parathyroid Glands / Q000502:physiology; D010293:Pargyline / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D011392:Proline; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013154:Spleen / Q000502:physiology; D013268:Stimulation, Chemical; D013737:Testis / Q000502:physiology; D013950:Thymus Gland / Q000502:physiology
D000577:Amides; D001679:Biogenic Amines; D010455:Peptides; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D011392:Proline; D010293:Pargyline; D007930:Leucine; D005998:Glycine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid